Phytomedicine : international journal of phytotherapy and phytopharmacology · 2025
Rhizoma Panacis Majoris ameliorates rheumatoid arthritis by restoring apoptosis and autophagy dysregulation through reducing HMGB1 expression.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Pang Xiayun, Song Ruotong, Li Zheng, Shi Xinbo, Zhang Zhen, Liu Yanru, Xu Hongbo, Song Zhongxing, Zhou Rui, Tang Zhishu
Аннотация
BACKGROUND: Restoring the autophagy and apoptosis balance in RA synovium may offer a promising RA treatment. Our previous research showed that total saponins from Rhizoma Panacis Majoris (RPMTG) exhibit anti-RA effects by inhibiting autophagy and inducing apoptosis. This study suggests that increased HMGB1 expression and reduced Beclin 1-Bcl-2 complex binding might be key mechanisms behind this dysregulation.
OBJECTIVE: This study investigated the anti-RA effects of RPMTG on collagen-induced arthritis (CIA) in rats and TNF-α-induced RA fibroblast-like synoviocytes (RA-FLSs), focusing on restoring autophagy and apoptosis balance through regulating HMGB1 expression and the Beclin 1-Bcl-2 complex binding.
METHODS: Beclin 1, Bcl-2, and HMGB1 expressions were analyzed using WB, IHC, and RT-qPCR. Beclin 1-Bcl-2 complex binding was examined by Co-IP. Autophagy morphology was observed via TEM, and apoptosis was assessed with Hoechst 33342/PI staining. RPMTG's therapeutic effect was evaluated through CIA rat symptoms and signs, inflammatory cytokine production via ELISA, and histopathological changes using HE staining. RPMTG's main component in drug-containing serum was determined by UPLC-Q-TOF-MS/MS.
RESULTS: The study found increased autophagy and decreased apoptosis in RA patients' synovial tissues compared to OA, which might link to higher HMGB1 levels and reduced Beclin 1-Bcl-2 binding. RPMTG effectively treated collagen-induced arthritis in rats by modulating Beclin 1, Bcl-2, and HMGB1 expression. It also reduced TNF-α-induced overproliferation in RA-FLSs and MH7A cells by lowering HMGB1 expression and enhancing the complex binding.
CONCLUSION: These findings emphasize the regulation of HMGB1 and Beclin 1-Bcl-2 complex in RA autophagy and apoptosis dysregulation, indicating RPMTG's potential for treating RA.
OBJECTIVE: This study investigated the anti-RA effects of RPMTG on collagen-induced arthritis (CIA) in rats and TNF-α-induced RA fibroblast-like synoviocytes (RA-FLSs), focusing on restoring autophagy and apoptosis balance through regulating HMGB1 expression and the Beclin 1-Bcl-2 complex binding.
METHODS: Beclin 1, Bcl-2, and HMGB1 expressions were analyzed using WB, IHC, and RT-qPCR. Beclin 1-Bcl-2 complex binding was examined by Co-IP. Autophagy morphology was observed via TEM, and apoptosis was assessed with Hoechst 33342/PI staining. RPMTG's therapeutic effect was evaluated through CIA rat symptoms and signs, inflammatory cytokine production via ELISA, and histopathological changes using HE staining. RPMTG's main component in drug-containing serum was determined by UPLC-Q-TOF-MS/MS.
RESULTS: The study found increased autophagy and decreased apoptosis in RA patients' synovial tissues compared to OA, which might link to higher HMGB1 levels and reduced Beclin 1-Bcl-2 binding. RPMTG effectively treated collagen-induced arthritis in rats by modulating Beclin 1, Bcl-2, and HMGB1 expression. It also reduced TNF-α-induced overproliferation in RA-FLSs and MH7A cells by lowering HMGB1 expression and enhancing the complex binding.
CONCLUSION: These findings emphasize the regulation of HMGB1 and Beclin 1-Bcl-2 complex in RA autophagy and apoptosis dysregulation, indicating RPMTG's potential for treating RA.